Replay available

Oscar Health, Inc. (OSCR) Q1 2025 Earnings Call

Oscar Health, Inc. (NYSE: OSCR) Q1 2025 earnings conference call, held 2025-05-07. Replay captured from the company's public earnings webcast.

Wed, May 7, 2025 at 8:00 AMendedReplay
Oscar Health, Inc. (OSCR) Q1 2025 Earnings Call

Investor webinar replay

Latest news releases

Companies on this event

Featured Presenters

Mark Berlini

Chief Executive Officer

Scott Blackley

Chief Financial Officer

John Ransom

Analyst, Raymond James

Stephen Baxter

Analyst, Wells Fargo

John Young

Analyst, UBS

Josh Raskin

Analyst, Necron Research

Jessica Towson

Analyst, Piper Sandler

Michael Ha

Analyst, Baird

Dave Windley

Analyst, Jefferies

Replay transcript excerpt

time. After the speaker's prepared remarks, there will be a question and answer session. If you'd like to ask a question during that time, please press star followed by one on your telephone keypad. Thank you. I will now like to turn the call over to Chris Potichar, Vice President of Treasury and Investor Relations. Good morning, everyone. Thank you for joining us for our first quarter 2025 earnings call. Mark Berlini, Oscar Held's Chief Executive Officer, and Scott Blackley, Oscar's Chief Financial Officer, will host this morning's call. This call can also be accessed through our investor relations website at ir.hioscar.com. Full details of our results and additional management commentary are available in our earnings release, which can be found on our investor relations website at ir.hioscar.com. Any remarks that Oster makes about the future constitute forward-looking statements within the meaning of safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements as a result of various important factors, including those discussed in our annual report on Form 10-K for the period ended December 31, 2024, filed with the SEC, and other filings with the SEC, including our quarterly report on Form 10-Q for the quarterly period ended March 31, 2025, to be filed with the SEC. Such forward-looking statements are based on current expectations as of today. Oster anticipates that subsequent events and developments may cause estimates to change. While the company may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so. The call will also refer to certain non-GAAP measures. A reconciliation of ...

More from Oscar Health, Inc.